Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Expert View
|
Dairy milk producers have been fighting a losing battle against categories such as carbonated soft drinks for the better part of a half century, with milk consumption in the US alone dropping over one third since the 1970s. Lately, however, some of the stiffest competition for dairy milk has come from within the milk category itself, with a host of new non-dairy options.
Published By Datamonitor
|
02 May 2013 |
|
CommentWire
|
A novel diagnostic tool, able to simultaneously screen for up to 30,000 different viruses, bacteria, fungi and parasites is currently being investigated by researchers at New York's Columbia University. Although its widespread availability requires more work, such a tool could help physicians give a more accurate diagnosis and prescribe appropriate treatment.
Published By Datamonitor
|
13 Dec 2006 |
|
Expert View
|
A Thursday morning breakfast meeting with GXS' chairman/CEO Harvey Seegers and marketing director Reid Walker saw both men in a relaxed yet excited mood regarding the company's future following its split from General Electric. Datamonitor's Martin Atherton found out more about the B2B vendor's plans for expansion...
Published By Datamonitor
|
05 Aug 2002 |
|
Expert View
|
The FSCP has called for the introduction of a range of straightforward "predictable outcome" products to reverse the loss of consumer trust experienced in the financial services sector. Changes to the advisory model through the introduction of the RDR and consumer demand for transparency and simplicity give strong weight to this proposal.
Published By Datamonitor
|
18 Aug 2011 |
|
Expert View
|
Teva has announced the EU approval of NOMAC/E2, the first monophasic contraceptive with natural estrogen. The perceived increased safety of natural estrogen and a global launch will drive sales of the product, making it a leading hormonal contraceptive brand. To maximize its potential, however, Teva needs to show improved safety over synthetic estrogen contraceptives in post-marketing studies.
Published By Datamonitor
|
03 Aug 2011 |
|
Expert View
|
The total amount of deposits and mutual funds held by non-residents in 12 of the largest offshore centers reached a post-crisis high of $14.2tn in 2011. However, this was still below the 2007 peak. Increased pressure on offshore centers to clean up their acts has limited their role as bases for tax avoidance for companies and individuals, to the benefit of safe havens such as the US and the UK.
Published By Datamonitor
|
25 Jul 2012 |
|
Expert View
|
Britain's pension system is about to undergo its most radical overhaul of the past 50 years. From April 6, 2006 - 'A-Day' - the current eight sets of pension taxation rules will be replaced by one. It is widely held that the simplified system will be attractive to those with some disposable income or who wish to make retirement provision but were deterred by the complexities of the former system.
Published By Datamonitor
|
05 Apr 2006 |
|
Expert View
|
While the internet has altered the landscape in the retail sector and revolutionized the airline industry, pharmaceutical companies have been slow to take advantage of the marketing opportunities offered by the medium. With existing sales and marketing strategies widely considered unsustainable, the industry needs to evolve and engage with its customers online, or it risks being left behind.
Published By Datamonitor
|
23 Apr 2008 |
|
Expert View
|
The average Brit is more likely than ever to load their trolley full of premium products. This is reflected by the growth of the specialty products such as hand-made, origin specific food, drink and personal care products. The growing taste for luxury is set to become more pronounced as consumers continue to experiment, self-reward and seek out satisfying experiences.
Published By Datamonitor
|
21 Jun 2005 |
|
CommentWire
|
With the release of positive Phase III clinical trial data, Boehringer Ingelheim's flibanserin has been found to offer significant benefit to sufferers of hypoactive sexual desire disorder. However, lower public acceptance of the disorder and uncertain demand will restrict the drug's commercial potential.
Published By Datamonitor
|
20 May 2010 |
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.